Vaccines Sales Pushed Pfizer Beyond The Expectations in the Final Quarter
The sales of the novel corona virus vaccine has been responsible for boosting the earnings of Pfizer pretty well past the expectations of the analyst in the final quarter of the year 2021, but the drug producing company has been setting a bar that is expected for the year 2022. On Tuesday, 8th February 2022, […]
Continue Reading